INPLASY202290015

Pembrolizumab in combination with chemotherapy vs. placebo in combination with chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis

Keywords: pembrolizumab, combination chemotherapy, triple-negative breast cancer, PD-1/PD-L1, meta-analysis.

Download PDF - 202290015

Review Status: Completed but not published